<?xml version="1.0" encoding="utf-8" ?><rss version="2.0" xmlns:News="http://www.bing.com/news/search?q=genzyme&amp;FORM=BNFD&amp;format=rss"><channel><title>genzyme - BingNews</title><link>http://www.bing.com/news/search?q=genzyme&amp;FORM=BNFD&amp;format=rss</link><description>Search results</description><image><url>http://www.bing.com/rsslogo.gif</url><title>genzyme</title><link>http://www.bing.com/news/search?q=genzyme&amp;FORM=BNFD&amp;format=rss</link></image><copyright>Copyright \xc2\xa9 2026 Microsoft. All rights reserved. These XML results may not be used, reproduced or transmitted in any manner or for any purpose other than rendering Bing results within an RSS aggregator for your personal, non-commercial use. Any other use of these results requires express written permission from Microsoft Corporation. By accessing this web page or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.</copyright><item><title>How Genzyme became a big source of biotech executives</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a1223858dcb48bf9b297480d17c6bf1&amp;url=https%3a%2f%2fwww.ksl.com%2farticle%2f35483984%2fhow-genzyme-became-a-big-source-of-biotech-executives&amp;c=16118233751743938293&amp;mkt=en-us</link><description>This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in ...</description><pubDate>Mon, 13 Jul 2015 06:01:00 GMT</pubDate><News:Source>KSL</News:Source></item><item><title>Genzyme Corporation and PTC Therapeutics Announce Collaboration on Small Molecule for Genetic Diseases</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a1223858dcb48bf9b297480d17c6bf1&amp;url=https%3a%2f%2fwww.fiercebiotech.com%2fbiotech%2fgenzyme-corporation-and-ptc-therapeutics-announce-collaboration-on-small-molecule-for&amp;c=10366623913396115732&amp;mkt=en-us</link><description>CAMBRIDGE, Mass. and SOUTH PLAINFIELD, N.J., July 17 /PRNewswire- FirstCall/ -- Genzyme Corporation (Nasdaq: GENZ) and PTC Therapeutics, Inc. (PTC) today announced an exclusive global collaboration to ...</description><pubDate>Thu, 17 Jul 2008 03:20:00 GMT</pubDate><News:Source>FierceBiotech</News:Source></item><item><title>Genzyme Submits All Information Requested by FDA for Lumizyme</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a1223858dcb48bf9b297480d17c6bf1&amp;url=https%3a%2f%2fwww.fiercebiotech.com%2fbiotech%2fgenzyme-submits-all-information-requested-by-fda-for-lumizyme&amp;c=12725728324201828213&amp;mkt=en-us</link><description>CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 21, 2009 - Genzyme Corporation (Nasdaq: GENZ) announced today that it has submitted the final documentation to address all items in the FDA's complete response ...</description><pubDate>Fri, 22 May 2009 00:46:00 GMT</pubDate><News:Source>FierceBiotech</News:Source></item><item><title>Genzyme rejects Sanofi offer as long battle looms</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a1223858dcb48bf9b297480d17c6bf1&amp;url=https%3a%2f%2fwww.reuters.com%2farticle%2fbusiness%2fhealthcare-pharmaceuticals%2fgenzyme-rejects-sanofi-offer-as-long-battle-looms-idUSTRE67T1JL%2f&amp;c=11758712674578627313&amp;mkt=en-us</link><description>PARIS/BOSTON (Reuters) - Biotech company Genzyme Inc rejected an $18.5 billion buyout offer from French drugmaker Sanofi-Aventis SA on Monday, setting the stage for a protracted and potentially ...</description><pubDate>Tue, 31 Aug 2010 09:04:00 GMT</pubDate><News:Source>Reuters</News:Source></item><item><title>Sanofi to Buy Genzyme for at Least $20.1B</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a1223858dcb48bf9b297480d17c6bf1&amp;url=https%3a%2f%2fwww.foxbusiness.com%2fmarkets%2fsanofi-to-buy-genzyme-for-at-least-20-1b&amp;c=13474896549233901709&amp;mkt=en-us</link><description>Ending nearly a year-long saga, Genzyme (NASDAQ:GENZ) agreed to a sweetened buyout from France’s Sanofi-Aventis (NYSE:SNY) on Wednesday that values the U.S. biotech giant at just north of $20 billion.</description><pubDate>Wed, 16 Feb 2011 03:01:00 GMT</pubDate><News:Source>Fox Business</News:Source></item><item><title>Genzyme to Acquire Novazyme Pharmaceuticals</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a1223858dcb48bf9b297480d17c6bf1&amp;url=https%3a%2f%2fnjbiz.com%2fgenzyme-to-acquire-novazyme-pharmaceuticals%2f&amp;c=6740549050061628090&amp;mkt=en-us</link><description>NJBIZ, New Jersey’s leading business journal, provides 24/7 business news coverage and events honoring top business professionals.</description><pubDate>Mon, 08 Aug 2005 17:00:00 GMT</pubDate><News:Source>NJBIZ</News:Source></item><item><title>Genzyme Gobbles Up Space in Framingham | Boston biotech’s appetite for space in MetroWest continues</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a1223858dcb48bf9b297480d17c6bf1&amp;url=https%3a%2f%2fwbjournal.com%2farticle%2fgenzyme-gobbles-up-space-in-framingham-boston-biotechs-appetite-for-space-in-metrowest%2f&amp;c=12625562878214902182&amp;mkt=en-us</link><description>Genzyme Corp. and Integrated Genetics, which both launched themselves in 1981, became one in 1989, and since then Genzyme has used IG’s 51 New York Ave. location in Framingham to keep expanding.</description><pubDate>Sun, 23 Nov 2008 16:00:00 GMT</pubDate><News:Source>WBJournal</News:Source></item><item><title>Genzyme Genetics Announces Launch of Carrier Testing and Prenatal Diagnosis for Spinal Muscular Atrophy</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a1223858dcb48bf9b297480d17c6bf1&amp;url=https%3a%2f%2fwww.fiercehealthcare.com%2fhealthcare%2fgenzyme-genetics-announces-launch-carrier-testing-and-prenatal-diagnosis-for-spinal&amp;c=5587940039016441012&amp;mkt=en-us</link><description>Genzyme Genetics is a leading, nationwide provider of high quality genetic testing and genetic counseling services for physicians and their patients. With laboratories and counseling facilities ...</description><pubDate>Mon, 14 Apr 2008 03:21:00 GMT</pubDate><News:Source>Fierce Healthcare</News:Source></item><item><title>Sanofi Genzyme puts hold on arthritis medicine following surge in side effects</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a1223858dcb48bf9b297480d17c6bf1&amp;url=https%3a%2f%2fwww.bostonglobe.com%2fbusiness%2f2017%2f12%2f08%2fsanofi-genzyme-recalls-arthritis-medicine-following-surge-side-effects%2fJDKQI2zMEHobUXna7qoyUN%2fstory.html&amp;c=17367252017684656036&amp;mkt=en-us</link><description>About 18,000 gel-filled syringes sold by the Cambridge biotech Sanofi Genzyme to treat arthritis of the knee should not be used because that batch was linked to a surge in side effects, the company ...</description><pubDate>Fri, 08 Dec 2017 10:15:00 GMT</pubDate><News:Source>The Boston Globe</News:Source></item><item><title>Genzyme, Icahn reach accord, ending proxy fight</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a1223858dcb48bf9b297480d17c6bf1&amp;url=https%3a%2f%2fwww.reuters.com%2farticle%2feconomy%2fgenzyme-icahn-reach-accord-ending-proxy-fight-idUSN09107620%2f&amp;c=6554276939677555231&amp;mkt=en-us</link><description>* Agreement comes ahead of annual meeting set for June 16 * Genzyme to appoint Steven Burakoff, Eric Ende directors * Icahn to withdraw slate of four nominees to board * Genzyme's shares rise 0.1 ...</description><pubDate>Wed, 09 Jun 2010 11:06:00 GMT</pubDate><News:Source>Reuters</News:Source></item><item><title>Genzyme Announces Winners of Patient Advocacy Leadership Awards</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a1223858dcb48bf9b297480d17c6bf1&amp;url=https%3a%2f%2fwww.fiercehealthcare.com%2fhealthcare%2fgenzyme-announces-winners-patient-advocacy-leadership-awards&amp;c=9014134543353700336&amp;mkt=en-us</link><description>CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), today announced the first recipients of the Genzyme Patient Advocacy Leadership (PAL) Awards. This global ...</description><pubDate>Wed, 17 Aug 2011 02:20:00 GMT</pubDate><News:Source>Fierce Healthcare</News:Source></item><item><title>Genzyme Pushes Forward With New, Upgraded Facilities</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a1223858dcb48bf9b297480d17c6bf1&amp;url=https%3a%2f%2fwbjournal.com%2farticle%2fgenzyme-pushes-forward-with-new-upgraded-facilities%2f&amp;c=13086597925438405259&amp;mkt=en-us</link><description>Dana Alexander, program director for Genzyme, shows off the company's new $170 million manufacturing facility in Framingham during a tour of the site on Tuesday. BRANDON BUTLER While Cambridge-based ...</description><pubDate>Tue, 11 May 2010 17:00:00 GMT</pubDate><News:Source>WBJournal</News:Source></item></channel></rss>